Published by Global Banking & Finance Review®
Posted on September 24, 2025
1 min readLast updated: January 21, 2026
Add as preferred source on GoogleGerresheimer shares fell 37% as Bafin investigates potential accounting violations, focusing on revenue recognition practices.
BERLIN (Reuters) -Shares in medical equipment maker Gerresheimer's plunged more than 37% on Wednesday after Germany's financial regulator said it had initiated an investigation into suspected accounting rule violations.
Watchdog Bafin said it would review Gerresheimer's consolidated financial statements as of November 30, 2024, adding the company may have recognized revenue for some contracts with customers before the revenue was actually realised.
The audit, looking into "specific" possible violations, includes the related management report, Bafin said in the statement.
Gerresheimer did not immediately respond to an emailed request for comment.
(Reporting by Bernadette Hogg and Ludwig Burger, editing by Kirsti Knolle)
Gerresheimer's shares dropped more than 37% after Germany's financial regulator, Bafin, announced an investigation into suspected accounting flaws.
Bafin is reviewing Gerresheimer's consolidated financial statements as of November 30, 2024, particularly focusing on possible violations related to revenue recognition.
Gerresheimer did not immediately respond to an emailed request for comment regarding the investigation.
Explore more articles in the Finance category
